Parsippany Chapter Upcoming Events Join PCCI

Monday, October 13, 2008

Embassy Suites, Chesterbrook, Pennsylvania (directions)

 

Nanomed Devices Inc

A clinical-stage drug repositioning company

Presenter: Bai Xu, CEO of Nanomed

About

 

Nanomed Devices, Inc. (Nanomed), founded in 2005, incorporated in Delaware, and based in Albany, NY, is a clinical-stage drug repositioning company focusing on developing and commercializing advanced drug delivery technology.

 

Nanomed's nanotechnology based intradermal delivery device is designed to safely and more effectively deliver drugs, including protein drugs that, until now, must be delivered by needle injection. It has a fully owned subsidiary in China where Nanomed has established high-quality, low-cost product development and manufacturing capability.

 

Nanomed successfully conducted a full scale human clinical trial for validating the clinical utilities of its proprietary Functional MicroArray (FMA ) drug delivery device, leading to SFDA (Chinese equivalent of FDA) approval of the product. The company successfully completed the Series A institutional funding to support its rapid growth.

 

Nanomed's patents, which extend protection of repositioned drugs through 2023 and beyond, presents significant developmental barriers to competitors who generally are left to modified transdermal systems. The result is often a less efficient, less desirable transdermal patch product. Nanomed's proprietary product FMA adds significant value to generic companies who seek product differentiation to capture value.

 

Nanomed's business strategy is to partner with companies and planning to first launch its product in emerging markets such as China. This approach is clearly less expensive, and offers lower risk and the potential for high return.

 

 

3 Major Issues

 

  1. What is a good business model for drug delivery startup company to assure fast growth?
  2. Is it better to position a drug delivery company as a drug reposition company to capture value?
  3. What is a meaningful exit strategy to convince potential investors

 

 

Program:

 

6:30 - Cocktails & Dinner (Cash bar and special 2-entree buffet menu)

8:00 - Bai Xu, CEO of Nanomed, will deliver the Company's "Elevator" Pitch to the Group

8:15 - A Panel will address 3 Major Issues for the Company

9:00 - Open discussion: members and guests

 

 

<Top of the page>

 

 

 

Available Media

Please note: All information obtained here is the property of those presenting and should not be copied or duplicated without written consent.

 

Slides

None available at this time

Audio

None available at this time

Video

None available at this time

Webcast

None available at this time

Contact Info:

Nanomed Devices Inc.

Tel: (518) 229-9628

Email: bxu@nanomed-devices.com

Web: nanomed-devices.com

 

Good Company! Good Drink! Good Food! Good Program! Good Fun!

 

Site Navigation

HOME  |  ABOUT PCCI  |   MAP / DIRECTIONS  |   JOIN US  |   BOARD MEMBERS  |   AFFILIATES  |  NEXT MEETING  |  ARCHIVES  |  PROFILES

CALENDAR OF EVENTS  |  PARSIPPANY CHAPTER  |  FEEDBACK / COMMENTS  |   CONTACT US

Pharmaceutical Consulting Consortium International, Inc.,

info@rxpcci.com or (610) 296-8086

Meetings Held at Embassy Suites - Valley Forge

888 Chesterbrook Blvd, Chesterbrook, Pennsylvania 19087

All content on this website is copyrighted and should not be reproduced without the consent of PCCI.

© Copyright 2016-2017

 

 

Tat Communication Inc